Unicycive Therapeutics, Inc. (UNCY)

Unicycive Therapeutics Statistics

Total Valuation

UNCY has a market cap or net worth of $75.42 million. The enterprise value is $53.50 million.

Market Cap	75.42M
Enterprise Value	53.50M

Important Dates

The last earnings date was Thursday, August 14, 2025, before market open.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

UNCY has 17.66 million shares outstanding. The number of shares has increased by 209.65% in one year.

Current Share Class	17.66M
Shares Outstanding	17.66M
Shares Change (YoY)	+209.65%
Shares Change (QoQ)	-0.66%
Owned by Insiders (%)	3.56%
Owned by Institutions (%)	12.68%
Float	13.66M

Valuation Ratios

PE Ratio	n/a
Forward PE	2.03
PS Ratio	n/a
Forward PS	0.70
PB Ratio	3.67
P/TBV Ratio	4.59
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.18, with a Debt / Equity ratio of 0.02.

Current Ratio	2.18
Quick Ratio	1.65
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-634.96

Financial Efficiency

Return on equity (ROE) is -131.87% and return on invested capital (ROIC) is -78.05%.

Return on Equity (ROE)	-131.87%
Return on Assets (ROA)	-51.00%
Return on Invested Capital (ROIC)	-78.05%
Return on Capital Employed (ROCE)	-185.51%
Revenue Per Employee	n/a
Profits Per Employee	-$1.37M
Employee Count	23
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +16.99% in the last 52 weeks. The beta is 1.87, so UNCY's price volatility has been higher than the market average.

Beta (5Y)	1.87
52-Week Price Change	+16.99%
50-Day Moving Average	4.84
200-Day Moving Average	5.86
Relative Strength Index (RSI)	45.70
Average Volume (20 Days)	481,181

Short Selling Information

The latest short interest is 1.22 million, so 6.93% of the outstanding shares have been sold short.

Short Interest	1.22M
Short Previous Month	1.42M
Short % of Shares Out	6.93%
Short % of Float	8.96%
Short Ratio (days to cover)	2.97

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-30.48M
Pretax Income	-36.93M
Net Income	-31.50M
EBITDA	-30.45M
EBIT	-30.48M
Earnings Per Share (EPS)	-$2.90

Balance Sheet

The company has $22.33 million in cash and $409,000 in debt, giving a net cash position of $21.92 million or $1.24 per share.

Cash & Cash Equivalents	22.33M
Total Debt	409,000
Net Cash	21.92M
Net Cash Per Share	$1.24
Equity (Book Value)	16.43M
Book Value Per Share	1.16
Working Capital	15.96M

Cash Flow

In the last 12 months, operating cash flow was -$33.12 million and capital expenditures -$68,000, giving a free cash flow of -$33.19 million.

Operating Cash Flow	-33.12M
Capital Expenditures	-68,000
Free Cash Flow	-33.19M
FCF Per Share	-$1.88

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

UNCY does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-209.65%
Shareholder Yield	-209.65%
Earnings Yield	-41.77%
FCF Yield	-44.01%

Analyst Forecast

The average price target for UNCY is $63.75, which is 1,392.97% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$63.75
Price Target Difference	1,392.97%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 20, 2025. It was a reverse split with a ratio of 1:10.

Last Split Date	Jun 20, 2025
Split Type	Reverse
Split Ratio	1:10

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a